Julie Peck October 22, 2025 With the supply of GLP-1 medications finally stabilizing as their use skyrocketed 600% among Americans from 2018 to 2024, the pharmaceutical landscape for anti-obesity medications is now poised to undergo another monumental shift. A rapid proliferation of drugs that show an unprecedented efficacy for treating this disease is expected over the […]
Anti-Obesity Medications Set to Explode Entering 2026 Read More »
Julie Peck October 22, 2025 29 2550 With the supply of GLP-1 medications finally stabilizing as their use skyrocketed 600% among Americans from 2018 to 2024, the pharmaceutical landscape for anti-obesity medications is now poised to undergo another monumental shift. A rapid proliferation of drugs that show an unprecedented efficacy for treating this disease is expected
Anti-Obesity Medications Set to Explode Entering 2026 Read More »
Emerging research indicates that phenotype-based testing may help identify which biologic process is driving an individual’s obesity, enabling clinicians to better tailor antiobesity medication (AOM) to the patient. Currently, patient response to AOMs varies widely, with some patients responding robustly to AOMs and others responding weakly or not at all. For example, trials of the
Can Nonresponders to Antiobesity Medicines Be Predicted? Read More »
by The Endocrine Society edited by Stephanie Baum, reviewed by Andrew Zinin Credit: CC0 Public Domain Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes, according to a new study being presented Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. Testosterone not only plays
Anti-obesity medications can normalize testosterone levels in men Read More »
Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.
✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866